Komori
Japan Medical Dynamic Marketing (7600) · FactCited as achieved

Recognition of a Gain on Debt Forgiveness Incurred in the United States

First written in FY2022-Q2. 2 of 4 entries say "Cited as achieved", first in FY2023-Q2. Latest entry: FY2023-Q3.

4entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseCited as achievedFY2022-Q2 – FY2023-Q32021: 120212022: 220222023: 12023
Same theme, other companies
Recognition of gain on debt forgivenessA theme 18 companies write about · 0 as a headwind · 18 as a tailwind

2 other companies' latest entry also says "Cited as achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 18 companies compared. The sentences above are computed from all 18.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q3Cited as achievedAnnual report

    「Profit attributable to owners of the parent was ¥1,138 million, down 30.3% year on year, mainly because a ¥306 million gain on debt forgiveness was recognized as extraordinary income in the previous period, in addition to the factors described above.」

    The ¥306 million gain on debt forgiveness recognized in the previous period is again cited as a factor behind the year-on-year decline in profit. The disclosure does not state that a gain on debt forgiveness was recognized in the current quarter.
  2. FY2023-Q2Cited as achievedAnnual report

    「Profit attributable to owners of the parent was ¥721 million, down 28.1% year on year, mainly because a ¥303 million gain on debt forgiveness was recognized as extraordinary income in the previous period, in addition to the factors described above.」

    The ¥303 million gain on debt forgiveness recognized in the previous period is cited as a factor behind the year-on-year decline in profit. No gain on debt forgiveness was recognized in the current quarter.
  3. FY2022-Q3Cumulative gain on debt forgiveness increasedAnnual report

    「Extraordinary items included ¥306 million in gain on debt forgiveness arising in the United States, recorded as extraordinary income, and ¥62 million in losses on disposal of medical instruments and other fixed assets, recorded as an extraordinary loss.」

    The gain on debt forgiveness arising in the United States was recognized at ¥303 million for the second quarter consolidated cumulative period and ¥306 million for the third quarter consolidated cumulative period.
  4. FY2022-Q2First statedAnnual report

    「Extraordinary items included ¥303 million in gain on debt forgiveness arising in the United States, recorded as extraordinary income, and ¥20 million in losses on disposal of medical instruments and other fixed assets, recorded as an extraordinary loss.」

    A ¥303 million gain on debt forgiveness arising in the United States was recognized for the first time as extraordinary income in the second quarter consolidated cumulative period.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Japan Medical Dynamic Marketing's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Recognition of a Gain on Debt Forgiveness Incurred in the United States | Japan Medical Dynamic Marketing,INC. (7600) | Komori